Encarnação, João Crispim
Schulte, Tim
Achour, Adnane
Björkelund, Hanna
Andersson, Karl
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (675555)
Vetenskapsrådet
Cancerfonden
Article History
Received: 26 December 2017
Revised: 5 March 2018
Accepted: 6 March 2018
First Online: 17 March 2018
Compliance with ethical standards
:
: Ridgeview Instruments AB (RIAB) develops and sells the device LigandTracer, which is described in the manuscript. João Encarnação, Hanna Björkelund, and Karl Andersson are employed by RIAB. Karl Andersson and Hanna Björkelund are shareholders of RIAB. RIAB acknowledges the adherence to all AMB policies on sharing data and materials. All equipment described in the report is commercially available, and no patents restrict the use of the described assays. Tim Schulte and Adnane Achour declare that they have nothing to disclose.
: This article does not contain any studies with human participants or animals performed by any of the authors.